Nanjing Jingzhu Bio-Tech

Nanjing Jingzhu Bio-Tech is a specialized contract research organization (CRO) focused on pharmaceutical solid-state chemistry and crystal engineering. The company provides a comprehensive suite of services including polymorph screening, salt and co-crystal selection, and crystallization process development for small molecule drug candidates. By optimizing the physical forms of active pharmaceutical ingredients (APIs), Jingzhu Bio-Tech helps clients enhance drug solubility, stability, and bioavailability. Their expertise is critical during the CMC (Chemistry, Manufacturing, and Controls) phase of drug development, supporting both regulatory filings and intellectual property strategies for global pharmaceutical partners.